Cold Urticaria Overview

Save information for later
Sign Up

Learn About Cold Urticaria

What is the definition of Cold Urticaria?
Cold urticaria is an allergic condition that affects the skin. Symptoms usually start in early adulthood. The most common symptom is a red, itchy rash that appears on the skin when it is exposed to the cold (e.g. cold weather or cold water). This reaction usually occurs within 5-10 minutes after exposure and can last for 1-2 hours. The exact cause of Cold urticaria is unknown. In some cases, it may be associated with an infection, insect bite, or blood cancer. It is diagnosed based on the symptoms and confirmed through tests that look for a specific reaction to cold.
What are the alternative names for Cold Urticaria?
  • Cold urticaria
  • Cold contact urticaria
  • Primary idiopathic cold urticaria
  • Urticaria idiopathic cold
Who are the top Cold Urticaria Local Doctors?

No local doctors have been found near Hazard, The United States. Expand the search radius or change your location here.

What are the latest Cold Urticaria Clinical Trials?
An Open Label Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults with Chronic Inducible Urticaria
An Open Label Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults with Chronic Inducible Urticaria
Enrollment Status: Recruiting
Publish Date: February 20, 2025
Intervention Type: Drug
Study Phase: Phase 2

Summary: This phase 2a trial will evaluate the safety and efficacy of EVO756 in subjects with chronic inducible urticaria, including symptomatic dermographism and cold urticaria.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 1b/2a, Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment With H1- Antihistamines
A Phase 1b/2a, Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment With H1- Antihistamines
Enrollment Status: Recruiting
Publish Date: November 04, 2024
Intervention Type: Drug
Study Phase: Phase 1/Phase 2

Summary: This is an open-label, single ascending dose Phase 1b/2a trial to determine the safety and tolerability and assess the preliminary efficacy of briquilimab in adult participants with Cold Urticaria (ColdU) or Symptomatic Dermographism (SD), who remain symptomatic despite treatment with H1 antihistamines. The trial will explore three ascending dose levels which will be tested in three sequential coh...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center